Singapore markets closed

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5400+0.1200 (+8.45%)
At close: 04:00PM EDT
1.4700 -0.07 (-4.55%)
Pre-market: 07:43AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.4200
Open1.4100
Bid1.4400 x 1200
Ask1.7000 x 3000
Day's range1.4100 - 1.6100
52-week range0.4800 - 13.6100
Volume367,220
Avg. volume3,280,124
Market cap43.69M
Beta (5Y monthly)1.01
PE ratio (TTM)N/A
EPS (TTM)-4.4820
Earnings date09 Nov 2022 - 14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.50
  • Motley Fool

    Acutus Medical, Inc. (AFIB) Q2 2022 Earnings Call Transcript

    Joining me on today's call is David Roman, chief executive officer and chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call do not relate to matters of historical fact should be considered forward-looking statements.

  • Motley Fool

    Acutus Medical, Inc. (AFIB) Q1 2022 Earnings Call Transcript

    Thank you for standing by, and welcome to the Acutus Medical, Inc. first quarter 2022 earnings conference call. Joining me on today's call are Scott Huennekens, chairman of Acutus's board of directors; and David Roman, interim chief executive officer and chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

  • Zacks

    Acutus Medical, Inc. (AFIB) Reports Q1 Loss, Tops Revenue Estimates

    Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -1.01% and 29.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?